-
1
-
-
42749090717
-
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
-
Amiaz R, Fostick L, Gershon A et al. Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study. Eur Neuropsychopharmacol 2008; 18 : 455-461
-
(2008)
Eur Neuropsychopharmacol
, vol.18
, pp. 455-461
-
-
Amiaz, R.1
Fostick, L.2
Gershon, A.3
-
2
-
-
0036726611
-
Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive-compulsive disorder?
-
Barbarich N. Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive-compulsive disorder? Eat Weight Disord 2002; 7 : 221-231
-
(2002)
Eat Weight Disord
, vol.7
, pp. 221-231
-
-
Barbarich, N.1
-
3
-
-
15844424547
-
Serotonergic and dopaminergic systems in anorexia nervosa: A role for atypical antipsychotics?
-
Bosanac P, Norman T, Burrows G et al. Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? J Aust N Z J Psychiatry 2005; 39 : 146-153
-
(2005)
J Aust N Z J Psychiatry
, vol.39
, pp. 146-153
-
-
Bosanac, P.1
Norman, T.2
Burrows, G.3
-
4
-
-
0032752095
-
Regulation of opioid receptors by opioid antagonists: Implications for rapid opioid detoxifi cation
-
Daws LC, White JM. Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxifi cation. Addiction Biology 1999; 4 : 391-397
-
(1999)
Addiction Biology
, vol.4
, pp. 391-397
-
-
Daws, L.C.1
White, J.M.2
-
5
-
-
16544392764
-
The role of dopamine in obsessivecompulsive disorder: Preclinical and clinical evidence
-
Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessivecompulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 2004; 65 (Suppl 14) : 11-17
-
(2004)
J Clin Psychiatry
, vol.65
, Issue.SUPPL. 14
, pp. 11-17
-
-
Denys, D.1
Zohar, J.2
Westenberg, H.G.3
-
7
-
-
0027521635
-
Are the eating disorders related to obsessive-compulsive disorder?
-
Hsu LK, Kaye W, Weltsin T. Are the eating disorders related to obsessive-compulsive disorder? Int J Eat Disord 1993; 14 : 305-318
-
(1993)
Int J Eat Disord
, vol.14
, pp. 305-318
-
-
Hsu, L.K.1
Kaye, W.2
Weltsin, T.3
-
8
-
-
0020572577
-
Naloxone administration in obsessive-compulsive disorder: Report of two cases
-
Insel TR, Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. Am J Psychiatry 1983; 140 : 1219-1220
-
(1983)
Am J Psychiatry
, vol.140
, pp. 1219-1220
-
-
Insel, T.R.1
Pickar, D.2
-
9
-
-
0029977409
-
Behavioral eff ects of naloxone infusion in obsessive-compulsive disorder
-
Keuler DJ, Altemus M, Michelson D et al. Behavioral eff ects of naloxone infusion in obsessive-compulsive disorder. Biol Psychiatry 1996; 40 : 154-156
-
(1996)
Biol Psychiatry
, vol.40
, pp. 154-156
-
-
Keuler, D.J.1
Altemus, M.2
Michelson, D.3
-
10
-
-
0034536720
-
Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder
-
Kruger S, Kennedy SH. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder. J Psychiatry Neurosci 2000; 25 : 497-508
-
(2000)
J Psychiatry Neurosci
, vol.25
, pp. 497-508
-
-
Kruger, S.1
Kennedy, S.H.2
-
12
-
-
0029066210
-
Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa
-
Marrazzi MA, Bacon JP, Kinzie J et al. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa. Int Clin Psychopharmacol 1995; 10 : 163-172
-
(1995)
Int Clin Psychopharmacol
, vol.10
, pp. 163-172
-
-
Marrazzi, M.A.1
Bacon, J.P.2
Kinzie, J.3
-
13
-
-
0030912223
-
Endogenous codeine and morphine in anorexia and bulimia nervosa
-
Marazzi MA, Luby ED, Kinzie J et al. Endogenous codeine and morphine in anorexia and bulimia nervosa. Life Sci 1997; 60 : 1741-1747
-
(1997)
Life Sci
, vol.60
, pp. 1741-1747
-
-
Marazzi, M.A.1
Luby, E.D.2
Kinzie, J.3
-
14
-
-
0028587287
-
Obsessive-compulsive spectrum disorder
-
discussion 52-53
-
MacElroy SL, Phillips KA, Keck PE Jr. Obsessive-compulsive spectrum disorder. J Clin Psychiatry 1994; 55 (Suppl) : 33-51; discussion 52-53
-
(1994)
J Clin Psychiatry
, vol.55
, Issue.SUPPL.
, pp. 33-51
-
-
MacElroy, S.L.1
Phillips, K.A.2
Keck Jr., P.E.3
-
15
-
-
85047682378
-
Clinical uses of naltrexone: A review of the evidence
-
Modesto-Lowe V, Kirk J Van. Clinical uses of naltrexone: a review of the evidence. Exp Clin Psychopharmacol 2002; 10 : 213-227
-
(2002)
Exp Clin Psychopharmacol
, vol.10
, pp. 213-227
-
-
Modesto-Lowe, V.1
Van Kirk, J.2
-
16
-
-
0023372605
-
Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome
-
Sandyk R. Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome. Int J Neurosci 1987; 35 : 93-94
-
(1987)
Int J Neurosci
, vol.35
, pp. 93-94
-
-
Sandyk, R.1
-
17
-
-
0034983220
-
Addiction and the brain: The role of neurotransmitters in the cause and treatment of drug dependence
-
Tomkins DM, Sellers EM. Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. Can Med Assoc 2001; 164 : 817-821
-
(2001)
Can Med Assoc
, vol.164
, pp. 817-821
-
-
Tomkins, D.M.1
Sellers, E.M.2
-
18
-
-
0030930590
-
A possible new treatment approach to obsessive-compulsive disorder
-
Warneke L. A possible new treatment approach to obsessive-compulsive disorder. Can J Psychiatry 1997; 42 : 667-668
-
(1997)
Can J Psychiatry
, vol.42
, pp. 667-668
-
-
Warneke, L.1
-
19
-
-
38849209876
-
Serotonin-induced platelet intracellular Ca 2+ response in patients with anorexia nervosa
-
Wockel L, Koch S, Stadler C et al. Serotonin-induced platelet intracellular Ca 2+ response in patients with anorexia nervosa. Pharmacopsychiatry 2008; 41 : W10-16
-
(2008)
Pharmacopsychiatry
, vol.41
-
-
Wockel, L.1
Koch, S.2
Stadler, C.3
|